Diabetes as a Risk Factor for Herpes Zoster Infection: Results of a Population-Based Study in Israel
Tóm tắt
Từ khóa
Tài liệu tham khảo
Aebi C, Fischer K, Gorgievski M, Matter L and Muhlemann K (2001). Age-specific seroprevalence to varicella-zoster virus: study in Swiss children and analysis of European data. Vaccine 19: 3097–3103
Geerlings S and Hoepelman A (1999). Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol 26: 259–265
Diabetes Control and Complications Trial Research Group (1995). The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med 122: 561–568
Ragozzino M, Melton L, Kurland L, Chu C and Perry H (1982). Population based study of herpes zoster and its sequelae. Medicine 61: 310–316
Brown G (1976). Herpes zoster: correlation of age, sex, distribution, neuralgia and associated disorders. South Med J 69: 576–578
Porter B (2004). The development of primary care in Israel. Isr Med Assoc J 6: 723–727
Peleg AY, Weerarathna T, McCarthy JS, Davis TM. Common infections in diabetes: pathogenesis, management and relationship to glycaemic control. Diabetes Metab Res Rev 2007; 23: 3–13
Brown G (1976). Herpes zoster: correlation of age, sex, distribution, neuralgia and associated disorders. South Med J 69: 576–578
Kaiserman I, Kaiserman N, Nakar S and Vinker S (2005). Herpetic eye disease in diabetic patients. Ophthalmology 112: 2184–2188
Kalman C and Laskin O (1986). Herpes zoster and zosteriform herpes simplex virus infections in immunocompetent adults. Am J Med 81: 775–778
Helgason S, Sigurdsson J and Gudmundsson S (1996). The clinical course of herpes zoster: a prospective study in primary care. Eur J Gen Pract 2: 12–16
Rubben A, Baron J and Grussendorf-Conen E (1997). Routine detection of herpes simplex virus and varicella zoster virus by polymerase chain reaction reveals that initial herpes zoster is frequently misdiagnosed as herpes simplex. Br J Dermatol 137: 259–261
Thomas S and Hall A (2004). What does epidemiology tells us about risk factors for herpes zoster?. Lancet Infect Dis 4: 26–33
McCormick A, Fleming D, Charlton J. (HM Stationery Office): Morbidity statistics from general practice: 4th national study 1991–92. A study carried out by the Royal College of General Practitioners, the Office of Population Censuses and Surveys, and the Department of Health 1995
de Melker H, Berbers G and Hahne S, et al. (2006). The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination. Vaccine 24: 3946–3952
Opstelten W, Schellevis F, Verheij T, Moons K and Essen G (2006). Gender as an independent risk factor for herpes zoster: a population-based prospective study. Ann Epidemiol 16: 692–695
Arndt V, Vine MF and Weigle K (1999). Environmental chemical exposures, risk of herpes zoster. Environ Health Perspect 107: 835–841
Moszczynski P, Zabinski Z, Moszczynski P Jr, Rutowski J, Slowinski S Jr and Tabarowski Z (2001). Immunological findings in cigarette smokers . Toxicol Lett 118: 121–127
Cook RT (1998). Alcohol abuse, alcoholism and damage to the immune system: a review. Alcohol Clin Exp Res 22: 1927–1942